A Study to Assess Change in Disease State in Adult Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy Receiving Oral Venetoclax Tablets in Canada

RecruitingOBSERVATIONAL
Enrollment

270

Participants

Timeline

Start Date

September 7, 2022

Primary Completion Date

March 31, 2027

Study Completion Date

March 31, 2027

Conditions
Acute Myeloid Leukemia
Trial Locations (20)

T2N 4N2

RECRUITING

Tom Baker Cancer Centre /ID# 248113, Calgary

T6G 2B7

RECRUITING

University of Alberta Hospital /ID# 251531, Edmonton

V3V 1Z2

RECRUITING

BC Cancer - Surrey /ID# 257515, Surrey

V5Z 1M9

RECRUITING

Vancouver General Hospital /ID# 245438, Vancouver

V8R 6V5

RECRUITING

BC Cancer - Victoria /ID# 257339, Victoria

R3E 0V9

RECRUITING

CancerCare Manitoba /ID# 246414, Winnipeg

E1C 6Z8

RECRUITING

The Moncton Hospital /ID# 247277, Moncton

A1B 3V6

RECRUITING

Eastern Regional Health Authority /ID# 250241, St. John's

B3H 2Y9

RECRUITING

QEII - Health Sciences Centre /ID# 246514, Halifax

L8V 1C3

RECRUITING

Juravinski Cancer Centre /ID# 247183, Hamilton

K7L 2V7

RECRUITING

Kingston Health Sciences Centre /ID# 253439, Kingston

N6A 5W9

RECRUITING

London Health Sciences Center- University Hospital /ID# 248027, London

L1G 2B9

RECRUITING

Lakeridge Health - Oshawa /ID# 246412, Oshawa

P7B 6V4

RECRUITING

Thunder Bay Regional Research Institute /ID# 249163, Thunder Bay

M4N 3M5

RECRUITING

Sunnybrook Health Sciences Ctr /ID# 251966, Toronto

M5G 2M9

RECRUITING

Princess Margaret Cancer Centre /ID# 249607, Toronto

H4A 3J1

RECRUITING

Royal Victoria Hospital / McGill University Health Centre /ID# 249704, Montreal

J1G 2E8

RECRUITING

CIUSSS de l'Estrie - CHUS /ID# 248915, Sherbrooke

S4T 7T1

RECRUITING

Allan Blair Cancer Centre /ID# 247663, Regina

S7N 4H4

RECRUITING

Saskatoon Cancer Centre /ID# 247181, Saskatoon

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY